Kalderos' 2023 Annual Report Highlights Costs of Systemic Challenges in Drug Discount Programs and Their Impact on Drug Manufacturers, Covered Entities, Payers and Patients

Kalderos, a data infrastructure and analytics company, has released its annual report highlighting the costs of systemic challenges in drug discount programs and their impact on all stakeholders. The report outlines a new paradigm of cooperation among drug discount program stakeholders that benefits everyone, particularly patients. The Medicaid Drug Rebate Program (MDRP), 340B Drug Pricing Progr..